Clinical Drug Experience Knowledgebase

Acute Coronary Syndrome (Phase 4)

Atrial Fibrillation (Phase 4)

Autoimmune Diseases (Phase 2)

Autoimmune Diseases of the Nervous System (Phase 2)

Bacteremia (Phase 3)

Brain Diseases (Phase 4)

Breast Neoplasms (Phase 2)

Cardiomyopathies (Phase 4)

Cardiomyopathy, Dilated (Phase 4)

Colitis, Ulcerative (Phase 4)

Communicable Diseases (Phase 3)

Critical Illness (Phase 1)

Crohn Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Embolism (Phase 2)

Endocarditis (Phase 2)

Endocarditis, Bacterial (Phase 2)

Endocarditis, Subacute Bacterial (Phase 2)

Enterobacteriaceae Infections (Phase 3)

Fibrosis (Phase 4)

Fractures, Bone (Phase 3)

Graft vs Host Disease (Phase 2)

Heart Failure (Phase 4)

Hepatic Encephalopathy (Phase 4)

Hepatitis (Phase 3)

Hepatitis B (Phase 3)

Hip Fractures (Phase 3)

HIV Infections (Phase 4)

Idiopathic Pulmonary Fibrosis (Phase 3)

Infections (Phase 3)

Intellectual Disability (Phase 2)

Latent Tuberculosis (Phase 3)

Liver Cirrhosis (Phase 4)

Mental Disorders (Phase 2)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 2)

Nervous System Diseases (Phase 2)

Pneumonia (Phase 3)

Pneumonia, Bacterial (Phase 3)

Pseudomonas Infections (Phase 3)

Psychotic Disorders (Phase 2)

Pulmonary Embolism (Phase 2)

Pulmonary Fibrosis (Phase 3)

Respiration Disorders (Phase 2)

Respiratory Tract Diseases (Phase 2)

Sclerosis (Phase 2)

Syndrome (Phase 4)

Thromboembolism (Phase 2)

Thrombosis (Phase 2)

Tuberculosis (Phase 3)

Venous Thrombosis (Phase 2)